Carboplatin Cipla Concentrate for Soln for Inf 10mg/ml (450mg/45ml) Malta - Inggeris - Medicines Authority

carboplatin cipla concentrate for soln for inf 10mg/ml (450mg/45ml)

cipla europe n.v. uitbreidingstraat 80, 2600 antwerp, belgium - carboplatin - concentrate for solution for infusion - carboplatin 10 mg/ml - antineoplastic agents

DBL CARBOPLATIN 450mg/45mL Injection vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

dbl carboplatin 450mg/45ml injection vial

pfizer australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections - carboplatin is indicated in the treatment of: advanced stage ovarian cancer of epithelial origin; small cell lung carcinoma; carcinoma of the head and neck; carcinoma of the testis; paediatric cerebral tumours; soft tissue sarcoma; neuroblastoma.

DBL CARBOPLATIN 150mg/15mL Injection vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

dbl carboplatin 150mg/15ml injection vial

pfizer australia pty ltd - carboplatin, quantity: 10 mg/ml - injection, solution - excipient ingredients: water for injections - carboplatin is indicated in the treatment of: advanced stage ovarian cancer of epithelial origin; small cell lung carcinoma; carcinoma of the head and neck; carcinoma of the testis; paediatric cerebral tumours; soft tissue sarcoma; neuroblastoma.

Carboplatin 450mg/45ml Solution for injection/concentrate for solution for infusion 450/45 Tanzania - Inggeris - Tanzania Medicinces & Medical Devices Authority

carboplatin 450mg/45ml solution for injection/concentrate for solution for infusion 450/45

sandoz gmbh, kundl, austria - carboplatin - solution for injection/concentrate for solution for infusion - 450/45

CARBOPLATIN ACCORD carboplatin 450 mg/45 mL solution for injection vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

carboplatin accord carboplatin 450 mg/45 ml solution for injection vial

accord healthcare pty ltd - carboplatin, quantity: 450 mg - injection, solution - excipient ingredients: water for injections - carboplatin is indicated in the treatment of: advanced stage ovarian cancer of epithelial origin. small cell lung carcinoma. carcinoma of the head and neck. carcinoma of the testis. paediatric cerebral tumours. soft tissue sarcoma. neuroblastoma.

CARBOPLATIN ACCORD carboplatin 150 mg/15 mL solution for injection vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

carboplatin accord carboplatin 150 mg/15 ml solution for injection vial

accord healthcare pty ltd - carboplatin, quantity: 150 mg - injection, solution - excipient ingredients: water for injections - carboplatin is indicated in the treatment of: advanced stage ovarian cancer of epithelial origin. small cell lung carcinoma. carcinoma of the head and neck. carcinoma of the testis. paediatric cerebral tumours. soft tissue sarcoma. neuroblastoma.

CARBOPLATIN ACCORD carboplatin 50 mg / 5 mL solution for injection vial Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

carboplatin accord carboplatin 50 mg / 5 ml solution for injection vial

accord healthcare pty ltd - carboplatin, quantity: 50 mg - injection, solution - excipient ingredients: water for injections - carboplatin is indicated in the treatment of: advanced stage ovarian cancer of epithelial origin. small cell lung carcinoma. carcinoma of the head and neck. carcinoma of the testis. paediatric cerebral tumours. soft tissue sarcoma. neuroblastoma.